LMTK2 anticorps (N-Term)
Aperçu rapide pour LMTK2 anticorps (N-Term) (ABIN2302665)
Antigène
Voir toutes LMTK2 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- N-Term
-
Réactivité croisée
- Humain
-
Réactivité croisée (Details)
- Calculated cross reactivity: Hu
-
Attributs du produit
- LMTK2, NT (Lemur Tyrosine Kinase 2, LMR2, Apoptosis-associated Tyrosine Kinase 2, AATYK2, Brain-enriched Kinase, BREK, hBREK, CDK5/p35-regulated Kinase, CPRK, FLJ46659, KIAA1079, Kinase/phosphatase/inhibitor 2, KPI2, KPI-2, Serine/threonine-protein Kinase LMTK2, Serine/threonine-protein Kinase KPI-2)
-
Purification
- Purified by Protein G affinity chromatography.
-
Immunogène
- Synthetic peptide selected from the N-terminal region of human LMTK2 (KLH).
-
Isotype
- IgG
-
-
-
-
Indications d'application
- Optimal working conditions should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- Supplied as a liquid in PBS, 0.09 % sodium azide.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C
-
Stockage commentaire
- -20°C
-
-
- LMTK2 (Lemur tyrosine Kinase 2 (LMTK2))
-
Autre désignation
- LMTK2
-
NCBI Accession
- NP_055731
-
UniProt
- Q8IWU2
-
Pathways
- Signalisation RTK, Neurotrophin Signaling Pathway
Antigène
-